📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Adalimumab in Psoriasis: How Much Is Enough? (2019)

First Author: Billi A

Attributed to: Improving diagnosis and treatment for the quantified patient funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2018.08.012

Publication URI: http://dx.doi.org/10.1016/j.jid.2018.08.012

Type: Journal Article/Review

Parent Publication: Journal of Investigative Dermatology

Issue: 1